Furthermore, when comparing the CE and PCOS groups, the expression levels of PERK and ATF4 were significantly higher in the PCOS patients (P < 0.05), whereas the protein expression of CHOP did not show a significant difference (P > 0.05). This evidence concerns the gene ATF4 and polycystic ovary syndrome.